-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
January 01, 2019 - NERVOUS SYSTEM DISORDERS W MCC 28,426 0.08%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 102,794 … SYSTEM W MCC 38,382 0.11%
92: OTHER DISORDERS OF NERVOUS SYSTEM W CC 60,392 0.17%
93: OTHER DISORDERS … OF NERVOUS SYSTEM W/O CC/MCC 29,371 0.08%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O
CC/MCC
3,924 0.01%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 188,484 0.53%
1: Large Central
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
January 01, 2016 - NERVOUS SYSTEM DISORDERS W MCC 20,067 0.12%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 80,893 … SYSTEM W MCC 17,899 0.10%
92: OTHER DISORDERS OF NERVOUS SYSTEM W CC 29,049 0.17%
93: OTHER DISORDERS … OF NERVOUS SYSTEM W/O CC/MCC 18,082 0.11%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O
CC/MCC
1,910 0.01%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 62,141 0.36%
1: Large Central
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
January 01, 2019 - SYSTEM NEOPLASMS W MCC 19,991 0.11%
55: NERVOUS SYSTEM NEOPLASMS W/O MCC 7,603 0.04%
56: DEGENERATIVE … NERVOUS SYSTEM DISORDERS W MCC 15,950 0.09%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 55,558 … OF NERVOUS SYSTEM W/O CC/MCC 16,162 0.09%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O
CC/MCC
2,047 0.01%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 126,995 0.70%
1: Large Central
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
January 01, 2018 - SYSTEM NEOPLASMS W MCC 20,377 0.12%
55: NERVOUS SYSTEM NEOPLASMS W/O MCC 8,154 0.05%
56: DEGENERATIVE … NERVOUS SYSTEM DISORDERS W MCC 16,700 0.09%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 54,909 … OF NERVOUS SYSTEM W/O CC/MCC 16,141 0.09%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O
CC/MCC
1,987 0.01%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 108,946 0.62%
1: Large Central
-
psnet.ahrq.gov/node/49631/psn-pdf
July 01, 2011 - patient-safety-and-adherence-self-administered-medications
The Case
A 30-year-old man, with HIV and a recent diagnosis of central … nervous system (CNS) toxoplasmosis,
returned to the emergency department (ED) of a community hospital
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
May 15, 2013 - synthetic marijuana * )
Prescription drugs for nonmedical purposes * (opioid pain relievers, central … nervous system depressants, stimulants)
Stimulants (cocaine, amphetamine * , methamphetamine
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/podcasts/The_Case_for_Improving_Patient_Experience_-2011_10_01_Transcript.pdf
January 01, 2011 - Larry Morrissey
Carla, we felt that giving patients a good experience was really central to the mission … It made people nervous, it made people worry.
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
January 01, 2019 - SYSTEM NEOPLASMS W MCC 405 0.01%
55: NERVOUS SYSTEM NEOPLASMS W/O MCC 793 0.03%
56: DEGENERATIVE NERVOUS … SYSTEM DISORDERS W MCC 490 0.02%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 1,635 0.05%
58: … OF NERVOUS SYSTEM W/O CC/MCC 3,442 0.11%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 637 0.02%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 10,767 0.35%
1: Large Central
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
January 01, 2016 - SYSTEM NEOPLASMS W MCC 369 0.01%
55: NERVOUS SYSTEM NEOPLASMS W/O MCC 935 0.03%
56: DEGENERATIVE NERVOUS … SYSTEM DISORDERS W MCC 509 0.02%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 1,540 0.05%
58: … OF NERVOUS SYSTEM W/O CC/MCC 3,513 0.11%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 784 0.03%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 11,886 0.38%
1: Large Central
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core.PDF
January 01, 2014 - NERVOUS SYSTEM DISORDERS W MCC 9,133 0.06%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 36,564 … OF NERVOUS SYSTEM W/O CC/MCC 15,033 0.10%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O
CC/MCC
1,690 0.01%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 62,337 0.42%
1: Large Central … 0.34%
9: Other OR therapeutic nervous system procedures 26,362 0.18%
10: Thyroidectomy; partial or
-
cds.ahrq.gov/taxonomy/term/57436
February 26, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
digital.ahrq.gov/electronic-prescribing-0
January 01, 2023 - During the 12 months of the study, the alert categories most often triggered were related to risks of central … nervous system side-effects, such as over-sedation (20 percent).
-
psnet.ahrq.gov/sites/default/files/2020-06/final_june-spotlight_case_slides_06.12.2020.pdf
January 01, 2020 - class of drugs is frequently associated with errors that can
result in adverse events including falls, central … nervous system
depression and respiratory depression
– Due to their high-risk nature, extra attention
-
psnet.ahrq.gov/node/73549/psn-pdf
July 28, 2021 - Anesthetic Systemic Toxicity (LAST) refers to complications affecting the cardiovascular (CVS) and
central … nervous (CNS) symptoms due to local anesthetic overdose.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
November 15, 2012 - These diseases in general
do not have central nervous system manifestations, although this may vary … There can be both central
and peripheral nervous system involvement in this
form of the disease, but
-
hcup-us.ahrq.gov/reports/statbriefs/sb157.pdf
March 01, 2013 - poisoning (combined) and respiratory disorders were the most common reasons for all ED
visits, followed by nervous … conditions
Skin and subcutaneous
tissue disorders
Digestive disorders
Infectious and parasitic diseases
Nervous … classification scheme for U.S. counties developed by the
National Center for Health Statistics (NCHS):
– Large Central … Metropolitan: Central counties of metropolitan areas with 1 million or more residents
– Large Fringe
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Severity.PDF
January 01, 2010 - system & related procedures 5,477 0.07%
40: Spinal disorders & injuries 1,897 0.02%
41: Nervous system … malignancy 10,086 0.13%
42: Degenerative nervous system disorders exc mult sclerosis 21,663 0.28% … system 3,125 0.04%
50: Non-bacterial infections of nervous system exc viral meningitis 3,615 0.05% … nos,uncomplicated intracranial injury,
coma < 1 hr or no coma
12,180 0.16%
58: Other disorders of nervous … 0.00%
NEU16: Multiple Sclerosis 6,026 0.08%
NEU17: Myasthenia Gravis 1,636 0.02%
NEU18: Neoplasm: Central
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
October 27, 2009 - EFFECTS-PHARMACEUTICAL TREATMENTS
1
Generic Name Brand Name Adverse Reaction
Ocular Cardiovascular
Central … Nervous
System/Psychiatry Other
Acetazolamide Diamox® • Transient myopia • Drowsiness,
• Paresthesia … Adverse events
AHRQ Agency for Health Related Quality
CAI Carbonic anhidrase inhibitors
CCT Central
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
March 22, 2023 - nervous system stimulants
- First-generation antipsychotics
- Selective serotonin reuptake inhibitors … alpha-Agonists/tu, ad
15. exp Anticonvulsants/tu, ad
16. exp Adrenergic beta-Antagonists/tu, ad
17. exp Central … Nervous System Stimulants/tu, ad
18. exp Antipsychotic Agents/tu, ad
19. exp Serotonin Uptake Inhibitors … (pharmacologi* or alpha agonist* or anticonvulsant* or antipsychotic* or (beta adj3 block*) or
((central … nervous system or CNS) adj3 stimulant*) or selective serotonin reuptake inhibitor* or
SSRI* or (mood
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core.PDF
January 01, 2017 - SYSTEM NEOPLASMS W MCC 20,094 0.11%
55: NERVOUS SYSTEM NEOPLASMS W/O MCC 9,671 0.05%
56: DEGENERATIVE … NERVOUS SYSTEM DISORDERS W MCC 23,262 0.13%
57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 83,711 … OF NERVOUS SYSTEM W/O CC/MCC 17,739 0.10%
94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O
CC/MCC
2,150 0.01%
97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS
PL_NCHS Frequency
Percent
of Total
.: Missing 90,821 0.51%
1: Large Central